Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Carroll

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluriaMatthew R D'Costa, Annamaria T Kausz, Kevin J Carroll, et al.
Journal of Nephrology|August 12, 2019
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxisVincent M Brandenburg, Smeeta Sinha, Jose-Vicente Torregrosa, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2025
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)Jaclyn A Smith, Surinder S Birring, Michael S Blaiss, et al.
The Lancet. Respiratory Medicine|September 13, 2024
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsCharles S Haworth, Michal Shteinberg, Kevin Winthrop, et al.
Clinical Kidney Journal|January 17, 2022
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxisSmeeta Sinha, Lisa J Gould, Sagar U Nigwekar, et al.
Eclinicalmedicine|September 10, 2024
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionSmeeta Sinha, Sagar U Nigwekar, Vincent Brandenburg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
British Journal of Cancer|September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2020
Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluriaMatthew R D'Costa, Annamaria T Kausz, Kevin J Carroll, et al.
Journal of Nephrology|August 12, 2019
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxisVincent M Brandenburg, Smeeta Sinha, Jose-Vicente Torregrosa, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2025
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)Jaclyn A Smith, Surinder S Birring, Michael S Blaiss, et al.
The Lancet. Respiratory Medicine|September 13, 2024
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsCharles S Haworth, Michal Shteinberg, Kevin Winthrop, et al.
Clinical Kidney Journal|January 17, 2022
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxisSmeeta Sinha, Lisa J Gould, Sagar U Nigwekar, et al.
Eclinicalmedicine|September 10, 2024
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionSmeeta Sinha, Sagar U Nigwekar, Vincent Brandenburg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
British Journal of Cancer|September 7, 2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerAngus G Dalgleish, Justin Stebbing, Douglas Ja Adamson, et al.
Pageof 3